PEAK innovator medicines representatives group Medicines Australia (MA) has welcomed the government's response to the Senate Community Affairs References Committee Report: 'Availability of new, innovative and specialist cancer drugs in Australia'.
The report recommended improvements to and streamlining of existing regulatory and assessment processes for new medicines, with many of the issues currently being addressed through reforms of the Therapeutic Goods Administration (TGA).
"In particular, we look forward to the passage of legislation currently before Parliament that includes provisions for another expedited pathway called Provisional Approval that aims to speed up access to new medicines," MA said.
"Not only does the Agreement provide $1.8 billion in savings on PBS listed medicines that will be used to pay for new treatments, the Government has committed to reform that will improve and accelerate processes that lead to a medicine being made available on the PBS," the organisation added.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Nov 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Nov 17
